Immune Tolerance in Cancer and Autoimmune Disease

Abcam, Inc.
Ultima Vez Modificado: 13 de febrero del 2009

Share article


English

Conference Dates: May 06 - 09, 2009
Conference Location: Antigua

Sponsoring Group: Abcam, Inc.

Conference Web Page URL: www.abcam.com/go.cfm?p=3321

Conference Objectives: Immune Tolerance in Cancer and Autoimmune Disease: how to break it, and how to (re-)make it.

Conference Agenda: Immune Tolerance in Cancer and Autoimmune Disease: how to break it, and how to (re-)make it.

Registration Information: The fee is fully inclusive of: conference registration and materials, including book of abstracts accommodation for the nights of May 6, 7 and 8 all meals, snacks and unlimited drinks transfers to/from the hotel in Antigua non-motorized water sports Early Bird (by Mar 6, 2009) Standard (by Mar 27, 2009) Single $995 $1195 Twin/Double $895 $995 Student (twin)* $795 $895 Partners ** $450 $500

Continuing Education: Yes

English
News
New Cervical Cancer Vaccine Targets HPV-Infected Women

Oct 11, 2012 - A new candidate vaccine designed to prevent cervical dysplasia and cancer in women already infected with human papillomavirus serotypes 16 and 18 is well tolerated and induces a robust immune response, according to a phase 1 study published in the Oct. 10 issue of Science Translational Medicine.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información